[go: up one dir, main page]

HUP0002335A3 - 2,3-dihydrofuro[3,2-b]pyridin derivatives, process for their preparation and application thereof in therapy - Google Patents

2,3-dihydrofuro[3,2-b]pyridin derivatives, process for their preparation and application thereof in therapy

Info

Publication number
HUP0002335A3
HUP0002335A3 HU0002335A HUP0002335A HUP0002335A3 HU P0002335 A3 HUP0002335 A3 HU P0002335A3 HU 0002335 A HU0002335 A HU 0002335A HU P0002335 A HUP0002335 A HU P0002335A HU P0002335 A3 HUP0002335 A3 HU P0002335A3
Authority
HU
Hungary
Prior art keywords
dihydrofuro
therapy
preparation
application
pyridin derivatives
Prior art date
Application number
HU0002335A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of HUP0002335A2 publication Critical patent/HUP0002335A2/hu
Publication of HUP0002335A3 publication Critical patent/HUP0002335A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU0002335A 1997-03-20 1998-03-17 2,3-dihydrofuro[3,2-b]pyridin derivatives, process for their preparation and application thereof in therapy HUP0002335A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703395A FR2761072B1 (fr) 1997-03-20 1997-03-20 Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
PCT/FR1998/000531 WO1998042713A1 (fr) 1997-03-20 1998-03-17 DERIVES DE 2,3-DIHYDROFURO[3,2-b]PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (2)

Publication Number Publication Date
HUP0002335A2 HUP0002335A2 (hu) 2001-05-28
HUP0002335A3 true HUP0002335A3 (en) 2002-07-29

Family

ID=9505006

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002335A HUP0002335A3 (en) 1997-03-20 1998-03-17 2,3-dihydrofuro[3,2-b]pyridin derivatives, process for their preparation and application thereof in therapy

Country Status (22)

Country Link
US (1) US6143761A (hu)
EP (1) EP0971929A1 (hu)
JP (1) JP2001518099A (hu)
KR (1) KR20000076282A (hu)
CN (1) CN1251105A (hu)
AR (1) AR012097A1 (hu)
AU (1) AU6924298A (hu)
BG (1) BG103684A (hu)
BR (1) BR9808346A (hu)
CA (1) CA2282320A1 (hu)
CO (1) CO4940417A1 (hu)
EE (1) EE9900414A (hu)
FR (1) FR2761072B1 (hu)
HU (1) HUP0002335A3 (hu)
IL (1) IL131254A0 (hu)
NO (1) NO994527L (hu)
NZ (1) NZ337566A (hu)
PL (1) PL335759A1 (hu)
SK (1) SK127699A3 (hu)
TR (1) TR199902115T2 (hu)
WO (1) WO1998042713A1 (hu)
ZA (1) ZA982365B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790474B1 (fr) * 1999-03-05 2001-04-06 Synthelabo Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
SE9902267D0 (sv) * 1999-06-16 1999-06-16 Astra Ab New compounds
JP2005104838A (ja) * 2003-01-09 2005-04-21 Tanabe Seiyaku Co Ltd 縮合フラン化合物
WO2006031856A2 (en) 2004-09-13 2006-03-23 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
ES2521494T3 (es) 2007-04-02 2014-11-12 Parkinson's Institute Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
AU2019279884B2 (en) 2018-05-29 2025-01-30 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0842178T3 (da) * 1995-07-28 2001-08-06 Abbott Lab Furopyridin, thienopyridin, pyrrolopyridin og beslægtede pyrimidin-, pyridazin- og triazinforbindelser, som er nyttige til regulering af kemisk synaptisk transmission

Also Published As

Publication number Publication date
US6143761A (en) 2000-11-07
SK127699A3 (en) 2000-05-16
EP0971929A1 (fr) 2000-01-19
CN1251105A (zh) 2000-04-19
CO4940417A1 (es) 2000-07-24
CA2282320A1 (en) 1998-10-01
IL131254A0 (en) 2001-01-28
NZ337566A (en) 2000-09-29
NO994527D0 (no) 1999-09-17
NO994527L (no) 1999-11-18
BG103684A (en) 2000-06-30
EE9900414A (et) 2000-04-17
AR012097A1 (es) 2000-09-27
PL335759A1 (en) 2000-05-22
TR199902115T2 (xx) 2000-01-21
BR9808346A (pt) 2000-05-23
HUP0002335A2 (hu) 2001-05-28
JP2001518099A (ja) 2001-10-09
FR2761072B1 (fr) 1999-04-23
ZA982365B (en) 1998-09-23
WO1998042713A1 (fr) 1998-10-01
AU6924298A (en) 1998-10-20
KR20000076282A (ko) 2000-12-26
FR2761072A1 (fr) 1998-09-25

Similar Documents

Publication Publication Date Title
IL119565A0 (en) Aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e] indol-8-ones derivatives thereof and their use
AP9901556A0 (en) Sulpponamide derivatives process for their preparation and their use as medicaments
HUP0000720A3 (en) Imidazo [1,2-a] pyridine derivatives, process for their preparation, pharmaceutical formulation containing them and their use
GB9510716D0 (en) Substituted camptothecin derivatives and process for their preparation
HUP0001922A3 (en) Pyrazolo[4,3-c]-pyridine derivatives, pharmaceutical compositions thereof against insulin resistance, intermediates and process for their preparation
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
AU1280100A (en) Novel 2-pyridone derivatives, preparation method and therapeutic use
PL327854A1 (en) Novel derivatives of benzoguanidin, method of obtaining them and their application in production of therapeutic agents
EE9900155A (et) 1H-pürido[3,4-b]indool-4-karboksamiidi derivaadid, nende valmistamismeetod ja kasutamine raviks
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
HK1028027A1 (en) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b)-indole-1-acetamide derivatives, their preparation and their application in therapy
HUP0003624A3 (en) 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives, pharmaceutical compositions containing them and process for their preparation
HUP0002335A3 (en) 2,3-dihydrofuro[3,2-b]pyridin derivatives, process for their preparation and application thereof in therapy
ZA981976B (en) Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
HUP9802407A3 (en) Process for preparing camptothecin derivatives and intermediates in their preparations
IL107133A0 (en) Piperidine derivatives,their preparation and their application in therapy
IL108343A0 (en) 9H-imidazo [1,2-a] benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application
HUP9602054A3 (en) Benzofuro- and benzothieno[3,2-b]pyridine derivatives, pharmaceutical compositions containing them, and process for the preparation thereof
SI0863139T1 (en) Benzoxazindione derivatives, process for their preparation and their use
ZA982369B (en) Dihydropyrazino[1,2-a]indol-1-one derivatives their preparation and their use in therapy
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
HUP0002659A3 (en) Benzo-5,6-cyclohepta[1,2-b]pyridine derivatives, pharmaceutical compositions containing them and their use
ZA904290B (en) 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives,their preparation and their application in therapy
ZA953749B (en) 5,6-dihydro-4H-thieno[3,4-c] pyrroie derivatives their preparation and their therapeutic application
ZA976828B (en) 6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine-3-acetic acid derivatives, their preparation and their application in therapy.